Evidence map›Paper›PMID 30840237›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2019

Mass Spectrometry-Based Proteomics to Define Intracellular Collagen Interactomes.

Ngoc-Duc Doan, Andrew S DiChiara, Amanda M Del Rosario, Richard P Schiavoni, Matthew D Shoulders

Abstract read
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Failed Cellular Surveillance Enables Pathogenic Matrix Deposition in abioRxiv : the preprint server for biology · 2025
    Article
  3. Article
  4. An outcome-defining role for the triple-helical domain in regulating collagen-I assembly.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  5. Article
  6. Review
  7. Collagen's enigmatic, highly conservedProceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  8. Article
  9. Article
  10. Article
  11. Targeting defective proteostasis in the collagenopathies.Current opinion in chemical biology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ngoc-Duc DoanDepartment of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA.
Andrew S DiChiaraDepartment of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA.
Amanda M Del RosarioKoch Institute, Massachusetts Institute of Technology, Cambridge, MA, USA.
Richard P SchiavoniKoch Institute, Massachusetts Institute of Technology, Cambridge, MA, USA.
Matthew D ShouldersDepartment of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA. mshoulde@mit.edu.

Funding

VIRUS PRODUCTION COREP30CA014051 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI Angela Nicole Koehler · 1985 to 2026
$93.9M
TOXICOLOGY CORE UNITP30ES002109 · NIEHS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI YAFFE, MICHAEL B · 1985 to 2020
$25.6M
Defining and Modulating Mechanisms of Collagen ProteostasisR01AR071443 · NIAMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI SHOULDERS, MATTHEW DONALD · 2017 to 2021
$1.7M
Unveiling the Proteostasis Network of Normal and Disease_Causing Collagen_IR03AR067503 · NIAMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI SHOULDERS, MATTHEW DONALD · 2015 to 2017
$234k
A Novel Approach to Osteogenesis Imperfecta_ The Collagen Protein Folding ProblemF31AR067615 · NIAMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI DICHIARA, ANDREW STEPHEN · 2015 to 2017
$127k
CIHRNCI NIH HHS P30 CA014051NIAMS NIH HHS F31 AR067615NIAMS NIH HHS R01 AR071443NIAMS NIH HHS R03 AR067503NIEHS NIH HHS P30 ES002109
6 · The paper itself

Abstract

We present the development, optimization, and application of constructs, cell lines, covalent cross-linking methods, and immunoprecipitation strategies that enable robust and accurate determination of collagen interactomes via mass spectrometry-based proteomics. Using collagen type-I as an example, protocols for working with large, repetitive, and GC-rich collagen genes are described, followed by strategies for engineering cells that stably and inducibly express antibody epitope-tagged collagen-I. Detailed steps to optimize collagen interactome cross-linking and perform immunoprecipitations are then presented. We conclude with a discussion of methods to elute collagen interactomes and prepare samples for mass spectrometry-mediated identification of interactors. Throughout, caveats and potential problems researchers may encounter when working with collagen are discussed. We note that the protocols presented herein may be readily adapted to define interactomes of other collagen types, as well as to determine comparative interactomes of normal and disease-causing collagen variants using quantitative isotopic labeling (SILAC)- or isobaric mass tags (iTRAQ or TMT)-based mass spectrometry analysis.

Indexed as

CollagenHumansImmunoprecipitationIntracellular SpaceIsotope LabelingMass SpectrometryProtein Interaction MappingProteomicsCollagenCo-immunoprecipitationCollagen proteostasis networkCross-linkingMass spectrometryProteomics

Identifiers

PMID30840237
PMCPMC6476175

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.